Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 3 May 2026 UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell... Read More Press release 1 May 2026 UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in... Read More Press release 30 Apr 2026 UCB’s General Meeting of Shareholders 2026 Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 3 May 2026 UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell... Read More
Press release 1 May 2026 UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in... Read More
